Clinical and laboratory changes during infliximab treatment
| Variables | Week 0 | Week 6 | Week 24 | Week 52 | p Value* |
|---|---|---|---|---|---|
| Results are shown as mean (SD). | |||||
| *Wilcoxon test for pairs, comparison between week 0 and week 52. | |||||
| Tender joints score | 6.4 (4.0) | 1.6 (1.5) | 1.8 (1.8) | 1.4 (1.8) | <0.05 |
| Swollen joints score | 2.6 (1.6) | 0.2 (0.4) | 0.2 (0.4) | 0.2 (0.4) | <0.05 |
| Patient self assessment | 6.9 (2.2) | 2.5 (2.6) | 2.4 (1.1) | 2.1 (1.1) | <0.05 |
| Physician self assessment | 6.7 (2.3) | 2.4 (1.4) | 2.4 (1.2) | 2.5 (1.4) | <0.05 |
| PASI score | 51.2 (14.0) | 10.0 (1.7) | 0.8 (0.5) | 0.8 (0.5) | <0.05 |
| CRP (mg/l) | 18.4 (16.7) | 2.6 (5.8) | 3.0 (3.3) | 1.6 (2.2) | <0.05 |
| ESR (mm/1st h) | 42.4 (18.0) | 16.2 (12.5) | 14.2 (8.8) | 12.8 (7.7) | <0.05 |